T1	Intervention 38 96	oral JAK inhibitor tofacitinib (CP-690,550) versus placebo
T2	Intervention 117 140	background methotrexate
T3	Intervention 216 235	methotrexate alone.
T4	Intervention 313 355	oral tofacitinib (CP-690,550) with placebo
T5	Intervention 463 481	methotrexate (MTX)
T6	Intervention 517 533	MTX monotherapy.
T7	Intervention 651 673	placebo or tofacitinib
T8	Intervention 835 839	MTX.
T9	Intervention 1030 1041	tofacitinib
T10	Intervention 1261 1272	for placebo
T11	Intervention 2000 2011	response to
T12	Intervention 2041 2064	addition of tofacitinib
